CellMark Belgium: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CellMark Belgium
Largest movements
- Receivables within one year +€473,630
up €473,630 (+52.9%), from €894,660 to €1.4m
of which Trade receivables: +€445,969
- Profit (loss) carried forward +€209,569
up €209,569 (+63.2%), from €331,509 to €541,078
- Short-term financial debts +€206,646
up €206,646 (+2,099%), from €9,847 to €216,493
- Trade debts +€106,386
up €106,386 (+624%), from €17,057 to €123,443
- Tax, wage and social debts -€57,660
down €57,660 (-26.3%), from €219,246 to €161,586
- Gross operating margin -€22,794
down €22,794 (-2.3%), from €1.0m to €978,627
- Financial income +€17,823
up €17,823 (+342%), from €5,210 to €23,033
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €918,089 | €1,389,252 | +€471,163 | +51.3% |
| Fixed assets | 21/28 | €16,519 | €12,848 | -€3,671 | -22.2% |
| Tangible fixed assets | 22/27 | €16,519 | €12,848 | -€3,671 | -22.2% |
| Furniture and vehicles | 24 | €16,519 | €12,848 | -€3,671 | -22.2% |
| Current assets | 29/58 | €901,570 | €1,376,404 | +€474,833 | +52.7% |
| Amounts receivable within one year | 40/41 | €894,660 | €1,368,290 | +€473,630 | +52.9% |
| Trade receivables | 40 | €42,515 | €488,485 | +€445,969 | +1,049% |
| Other amounts receivable | 41 | €852,145 | €879,805 | +€27,661 | +3.2% |
| Deferred charges and accrued income | 490/1 | €6,910 | €8,114 | +€1,204 | +17.4% |
| Total equity and liabilities | 10/49 | €918,089 | €1,389,252 | +€471,163 | +51.3% |
| Equity | 10/15 | €662,609 | €872,178 | +€209,569 | +31.6% |
| Contributions | 10/11 | €301,000 | €301,000 | = | 0.0% |
| Capital | 10 | €301,000 | €301,000 | = | 0.0% |
| Issued capital | 100 | €301,000 | €301,000 | = | 0.0% |
| Reserves | 13 | €30,100 | €30,100 | = | 0.0% |
| Non-distributable reserves | 130/1 | €30,100 | €30,100 | = | 0.0% |
| Legal reserve | 130 | €30,100 | €30,100 | = | 0.0% |
| Profit (loss) carried forward | 14 | €331,509 | €541,078 | +€209,569 | +63.2% |
| Amounts payable | 17/49 | €255,480 | €517,074 | +€261,593 | +102% |
| Amounts payable within one year | 42/48 | €246,150 | €501,522 | +€255,372 | +104% |
| Financial debts | 43 | €9,847 | €216,493 | +€206,646 | +2,099% |
| Other loans | 439 | €9,847 | €216,493 | +€206,646 | +2,099% |
| Trade debts | 44 | €17,057 | €123,443 | +€106,386 | +624% |
| Suppliers | 440/4 | €17,057 | €123,443 | +€106,386 | +624% |
| Taxes, remuneration and social security | 45 | €219,246 | €161,586 | -€57,660 | -26.3% |
| Remuneration and social security | 454/9 | €219,246 | €161,586 | -€57,660 | -26.3% |
| Accrued charges and deferred income | 492/3 | €9,330 | €15,552 | +€6,221 | +66.7% |
| Remuneration, social security and pensions | 62 | €784,506 | €782,091 | -€2,416 | -0.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,861 | €3,671 | +€1,810 | +97.3% |
| Other operating charges | 640/8 | €200 | €244 | +€44 | +22.1% |
| Gross operating margin | 9900 | €1,001,421 | €978,627 | -€22,794 | -2.3% |
| Operating profit (loss) | 9901 | €214,854 | €192,622 | -€22,233 | -10.3% |
| Financial income | 75/76B | €5,210 | €23,033 | +€17,823 | +342% |
| Recurring financial income | 75 | €5,210 | €23,033 | +€17,823 | +342% |
| Financial charges | 65/66B | €5,164 | €6,086 | +€922 | +17.8% |
| Recurring financial charges | 65 | €5,164 | €6,086 | +€922 | +17.8% |
| Profit (loss) for the period before taxes | 9903 | €214,900 | €209,569 | -€5,331 | -2.5% |
| Income taxes | 67/77 | €848 | - | -€848 | |
| Profit (loss) for the period | 9904 | €214,051 | €209,569 | -€4,482 | -2.1% |
| Profit (loss) for the period to be appropriated | 9905 | €214,051 | €209,569 | -€4,482 | -2.1% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 19 October 2026 via checked.be.